These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1568287)

  • 41. Effect of electroporation on cell killing by boron neutron capture therapy using borocaptate sodium (10B-BSH).
    Ono K; Kinashi Y; Masunaga S; Suzuki M; Takagaki M
    Jpn J Cancer Res; 1998 Dec; 89(12):1352-7. PubMed ID: 10081497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The diuretic effect of borocaptate sodium in rats and in patients with brain tumors.
    Horn V; Slánsky J; Buchar E; Janku I; Sourek K; Tovarys F
    Methods Find Exp Clin Pharmacol; 1997 Oct; 19(8):559-66. PubMed ID: 9442480
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Large animal normal tissue tolerance using an epithermal neutron beam and borocaptate sodium.
    Gavin PR; Huiskamp R; Wheeler FJ; Kraft SL; DeHaan CE
    Strahlenther Onkol; 1993 Jan; 169(1):48-56. PubMed ID: 8434340
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spectromicroscopy of boron in human glioblastomas following administration of Na2B12H11SH.
    Gilbert B; Perfetti L; Fauchoux O; Redondo J; Baudat PA; Andres R; Neumann M; Steen S; Gabel D; Mercanti D; Ciotti MT; Perfetti P; Margaritondo G; De Stasio G
    Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics; 2000 Jul; 62(1 Pt B):1110-8. PubMed ID: 11088567
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effectiveness of the high-LET radiations from the boron neutron capture [10B(n,α) 7Li] reaction determined for induction of chromosome aberrations and apoptosis in lymphocytes of human blood samples.
    Schmid TE; Canella L; Kudejova P; Wagner FM; Röhrmoser A; Schmid E
    Radiat Environ Biophys; 2015 Mar; 54(1):91-102. PubMed ID: 25428113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide.
    Michiue H; Sakurai Y; Kondo N; Kitamatsu M; Bin F; Nakajima K; Hirota Y; Kawabata S; Nishiki T; Ohmori I; Tomizawa K; Miyatake S; Ono K; Matsui H
    Biomaterials; 2014 Mar; 35(10):3396-405. PubMed ID: 24452095
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The combined effect of boronophenylalanine and borocaptate in boron neutron capture therapy for SCCVII tumors in mice.
    Ono K; Masunaga S; Suzuki M; Kinashi Y; Takagaki M; Akaboshi M
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):431-6. PubMed ID: 10030272
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Boron microlocalization in oral mucosal tissue: implications for boron neutron capture therapy.
    Morris GM; Smith DR; Patel H; Chandra S; Morrison GH; Hopewell JW; Rezvani M; Micca PL; Coderre JA
    Br J Cancer; 2000 Jun; 82(11):1764-71. PubMed ID: 10839288
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell type selective accumulation of mercaptoundecahydro- closo-dodecaborate (BSH) in glioblastoma multiforme.
    Neumann M; Bergmann M; Gabel D
    Acta Neurochir (Wien); 2003 Nov; 145(11):971-5. PubMed ID: 14628202
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New functionalized mercaptoundecahydrododecaborate derivatives for potential application in boron neutron capture therapy: synthesis, characterization and dynamic visualization in cells.
    Genady AR; Ioppolo JA; Azaam MM; El-Zaria ME
    Eur J Med Chem; 2015 Mar; 93():574-83. PubMed ID: 25748122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of high boron content liposomes and their promising antitumor effect for neutron capture therapy of cancers.
    Koganei H; Ueno M; Tachikawa S; Tasaki L; Ban HS; Suzuki M; Shiraishi K; Kawano K; Yokoyama M; Maitani Y; Ono K; Nakamura H
    Bioconjug Chem; 2013 Jan; 24(1):124-32. PubMed ID: 23214414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changed delivery of boron to tumours using electroporation for boron neutron capture therapy with BSH.
    Cemazar M; Skrk J; Mitrovic B; Sersa G
    Br J Radiol; 2000 Feb; 73(866):195-200. PubMed ID: 10884734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A bystander effect observed in boron neutron capture therapy: a study of the induction of mutations in the HPRT locus.
    Kinashi Y; Masunaga S; Nagata K; Suzuki M; Takahashi S; Ono K
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):508-14. PubMed ID: 17418970
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Performance of sulfhydryl boron hydride in patients with grade III and IV astrocytoma: a basis for boron neutron capture therapy.
    Ceberg CP; Persson A; Brun A; Huiskamp R; Fyhr AS; Persson BR; Salford LG
    J Neurosurg; 1995 Jul; 83(1):79-85. PubMed ID: 7782854
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sodium mercaptoundecahydro-closo-dodecaborate (BSH), a boron carrier that merits more attention.
    Wittig A; Stecher-Rasmussen F; Hilger RA; Rassow J; Mauri P; Sauerwein W
    Appl Radiat Isot; 2011 Dec; 69(12):1760-4. PubMed ID: 21420870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
    Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of carborane-containing porphyrins as tumour targeting agents for boron neutron capture therapy.
    Miura M; Micca PL; Fisher CD; Gordon CR; Heinrichs JC; Slatkin DN
    Br J Radiol; 1998 Jul; 71(847):773-81. PubMed ID: 9771389
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pilot clinical study of boron neutron capture therapy for recurrent hepatic cancer involving the intra-arterial injection of a (10)BSH-containing WOW emulsion.
    Yanagie H; Higashi S; Seguchi K; Ikushima I; Fujihara M; Nonaka Y; Oyama K; Maruyama S; Hatae R; Suzuki M; Masunaga S; Kinashi T; Sakurai Y; Tanaka H; Kondo N; Narabayashi M; Kajiyama T; Maruhashi A; Ono K; Nakajima J; Ono M; Takahashi H; Eriguchi M
    Appl Radiat Isot; 2014 Jun; 88():32-7. PubMed ID: 24559940
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Boron-enriched streptavidin potentially useful as a component of boron carriers for neutron capture therapy of cancer.
    Sano T
    Bioconjug Chem; 1999; 10(5):905-11. PubMed ID: 10502360
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined use of sodium borocaptate and buthionine sulfoximine in boron neutron capture therapy enhanced tissue boron uptake and delayed tumor growth in a rat subcutaneous tumor model.
    Yoshida F; Yamamoto T; Nakai K; Kumada H; Shibata Y; Tsuruta W; Endo K; Tsurubuchi T; Matsumura A
    Cancer Lett; 2008 May; 263(2):253-8. PubMed ID: 18272285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.